<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>33(16)</volume><submitter>Kerkela R</submitter><pubmed_abstract>Small-molecule inhibition of hypoxia-inducible factor prolyl 4-hydroxylases (HIF-P4Hs) is being explored for the treatment of anemia. Previous studies have suggested that HIF-P4H-2 inhibition may also protect the heart from an ischemic insult. Hif-p4h-2(gt/gt) mice, which have 76 to 93% knockdown of Hif-p4h-2 mRNA in endothelial cells, fibroblasts, and cardiomyocytes and normoxic stabilization of Hif-α, were subjected to ligation of the left anterior descending coronary artery (LAD). Hif-p4h-2 deficiency resulted in increased survival, better-preserved left ventricle (LV) systolic function, and a smaller infarct size. Surprisingly, a significantly larger area of the LV remained perfused during LAD ligation in Hif-p4h-2(gt/gt) hearts than in wild-type hearts. However, no difference was obse</pubmed_abstract><journal>Molecular and cellular biology</journal><pagination>3321-9</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3753900</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Activation of hypoxia response in endothelial cells contributes to ischemic cardioprotection.</pubmed_title><pmcid>PMC3753900</pmcid><pubmed_authors>Pietila I</pubmed_authors><pubmed_authors>Sormunen R</pubmed_authors><pubmed_authors>Koch WJ</pubmed_authors><pubmed_authors>Gao E</pubmed_authors><pubmed_authors>Koivunen P</pubmed_authors><pubmed_authors>Vainio L</pubmed_authors><pubmed_authors>Alitalo K</pubmed_authors><pubmed_authors>Kivirikko KI</pubmed_authors><pubmed_authors>Serpi R</pubmed_authors><pubmed_authors>Anisimov A</pubmed_authors><pubmed_authors>Magga J</pubmed_authors><pubmed_authors>Myllyharju J</pubmed_authors><pubmed_authors>Kerkela R</pubmed_authors><pubmed_authors>Szabo Z</pubmed_authors><pubmed_authors>Karsikas S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Activation of hypoxia response in endothelial cells contributes to ischemic cardioprotection.</name><description>Small-molecule inhibition of hypoxia-inducible factor prolyl 4-hydroxylases (HIF-P4Hs) is being explored for the treatment of anemia. Previous studies have suggested that HIF-P4H-2 inhibition may also protect the heart from an ischemic insult. Hif-p4h-2(gt/gt) mice, which have 76 to 93% knockdown of Hif-p4h-2 mRNA in endothelial cells, fibroblasts, and cardiomyocytes and normoxic stabilization of Hif-α, were subjected to ligation of the left anterior descending coronary artery (LAD). Hif-p4h-2 deficiency resulted in increased survival, better-preserved left ventricle (LV) systolic function, and a smaller infarct size. Surprisingly, a significantly larger area of the LV remained perfused during LAD ligation in Hif-p4h-2(gt/gt) hearts than in wild-type hearts. However, no difference was obse</description><dates><release>2013-01-01T00:00:00Z</release><publication>2013 Aug</publication><modification>2025-04-04T22:06:46.926Z</modification><creation>2019-03-27T01:15:07Z</creation></dates><accession>S-EPMC3753900</accession><cross_references><pubmed>23775121</pubmed><doi>10.1128/MCB.00432-13</doi><doi>10.1128/mcb.00432-13</doi></cross_references></HashMap>